1 / 37

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2. Dr. Vinod Sanghi MD. Overview of Diagnosed and Undiagnosed Diabetes in the United States—2000. Diabetes in India. People with Diabetes : 40 million In 2025 : About 70 million people with diabetes DIABETES CAPITAL OF THE WORLD.

bryant
Download Presentation

Diabetes Mellitus Type 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Diabetes Mellitus Type 2 Dr. Vinod Sanghi MD

  2. Overview of Diagnosed and Undiagnosed Diabetes in the United States—2000

  3. Diabetes in India People with Diabetes : 40 million In 2025 : About 70 million people with diabetes DIABETES CAPITAL OF THE WORLD

  4. Diabetes Major impact on Morbidity & Mortality Diabetes can lead to : Coronary heart disease Diabetic retinopathy Diabetic neuropathy Diabetic nephropathy

  5. Diabetes Prevalence, 1990-2001

  6. Diabetes in India Diabetes is increasing in India Fast food Lack of exercise

  7. Estimated Costs of Diabetes in the United States—2002

  8. Prevalence of Diabetes* in the United States According to Age and Sex—2000

  9. Estimated Prevalence of Diabetes in Global Adult Population—1995-2025

  10. DCCT: Effects of Intensive vs Conventional Glycemic Control

  11. UKPDS: Design

  12. UKPDS: Effects of Intensive (Sulfonylurea/Insulin) Treatment

  13. UKPDS: Effects of Intensive (Metformin) Treatment*

  14. UKPDS: Risk Reduction in Diabetes-Related Complications (A1C)

  15. UKPDS: Effects of Tight vs Less-Tight Blood Pressure Control

  16. The 4S Diabetes Substudy

  17. The CARE Trial: Reduction of Coronary Events in Subjects With and Without Diabetes

  18. Evidence Supporting Multiple Risk Factor Reduction

  19. Multifactorial Intervention in Patients With Type 2 Diabetes: Steno-2 Study—Design

  20. Multifactorial Intervention in Patients With Type 2 Diabetes: Steno-2 Study—Treatment Goals

  21. Multifactorial Intervention in Patients With Type 2 Diabetes: Steno-2 Study—CV Events

  22. Pathophysiologyof Type 2 Diabetes andInsulin Resistance

  23. Insulin Resistance

  24. Natural History of Type 2 Diabetes

  25. Development of Type 2 Diabetes

  26. Hyperglycemia in Type 2 Diabetes Results From Three Major Metabolic Defects

  27. Insulin Resistance: Associated Conditions

  28. Standards of Care forGlycemia, Lipids, and Hypertension

  29. 2003 ADA Recommendations for Glycemic Control in Type 2 Diabetes

  30. 2003 ADA Lipid Targets in Type 2 Diabetes

  31. 2003 ADA Treatment Recommendations for Hypertension and Nephropathy

  32. NCEP: Diabetes as CHD Risk Equivalent

  33. NCEP: Metabolic Syndrome

  34. NCEP: Clinical Identification of the Metabolic Syndrome* (Indian : >35in) (Indian : >30in)

  35. Diabetes Prevention Program: Reduction in Diabetes Incidence

  36. Diabetes Prevention Program: Summary

  37. AACE Guidelines for the Management of Type 2 Diabetes

More Related